PMA Insights: Week 41


  NICE recommends first treatment in two decades for sickle cell disease

  WHO committee recommends action on high-priced essential medicines

 Majority of U.S. voters approve of giving Medicare drug price negotiation authority

 Northern Ireland could face medicine shortages after Brexit grace period ends next year

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.